BioClin has been acquired by Trimb Healthcare
Orange Pearl International has sold BioClin, a leading healthcare products company, to Trimb Healthcare AB, a Swedish pharmaceutical company.
Based in the Netherlands, BioClin sells products to provide direct treatment and relief for women’s intimate health discomforts. The company’s product portfolio consists of Multi-Gyn, a complete range for treating intimate discomforts and Multi-Mam, a product range of self-care products for mothers and babies. BioClin’s brands are growing rapidly and are sold in pharmacies and drugstores in over 60 countries worldwide.
Trimb Healthcare is rapidly growing pharmaceutical company with a focus on sales, marketing and development of prescription-free OTC pharmaceuticals and consumer healthcare products.
Oaklins' team in the Netherlands acted as the exclusive sell-side advisor to the shareholders of BioClin in this transaction.
Talk to the deal team
Related deals
Hemink Groep has been acquired by Gimv
Gimv has acquired a majority stake in Hemink, a Dutch specialist in real estate renovation and maintenance. This transaction marks a new chapter for Hemink, as it seeks to expand its position as a national leader in sustainable property services through its new partnership with Gimv.
Learn moreOGD has been sold to Building Beyond Technology Group
Building Beyond Technology Group (BBTG) strengthens its position in the IT sector by welcoming OGD IT-Dienstverlening (OGD) to its platform. With over 1,400 employees, OGD is an established name in the Dutch market as a mission-critical IT service provider for large-scale clients. This addition not only increases BBTG’s scale but also enhances its domain expertise and execution capabilities through close cooperation with the other platform companies.
Learn moreThe Providence Projects has been acquired by UKAT Group
Celebrity-success rehabilitation center, The Providence Projects, has joined The UK Addiction Treatment (UKAT) Group, backed by Sullivan Street Equity Partners.
Learn more